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What do people die from? The challenges
of measuring disease burden posed by
multi-morbidity
Martin McKee
Abstract
Determining the precise cause of death of an individual has become increasingly difficult as life prolonging
treatments mean that many people may die with multiple disorders, any of which, individually or in concert, might
have killed them. Yet this problem has been recognised from the very earliest attempts to develop classifications of
diseases. This paper traces the evolution of thinking on death certification and disease classification, describing
what has been achieved but also identifying what more needs to be done to advance research and inform policy.
Background
In the accompanying paper Goldberger and colleagues
illustrate clearly the challenges of making international
comparisons of disease burden [1]. They seek to explain
the observation that reported death rates from cardio-
vascular disease in Israel are low but those from diabetes
and renal failure are high. Taking advantage of data on
multiple causes of death, they conclude that the seemingly
high rates of diabetes and renal failure may in part be
attributed to coding practices and some of these deaths
might be attributed to cardiovascular disease elsewhere.
However this does not provide a complete explanation,
indicating the need for an appropriate policy response.
The emergence of disease classifications
Their paper addresses a question that is superficially sim-
ple but, in reality, very complex [2]. What do people die
from? Historically, if physicians stated any cause of death
at all, it would be arbitrary, reflecting their often idiosyn-
cratic habits or the tradition of the medical school in
which they trained. By the eighteenth century several
physicians who were also botanists, such as Linnaeus,
sought to describe and then classify causes, just as they
had done with plants. Yet, given the very limited contem-
porary understanding of pathology and thus the inability
to link many deaths to particular organs, the results were
based on little more than symptoms or mode of death. By
the mid-nineteenth century William Farr in England [3]
and Marc d’Espine in Geneva [4] had provided the basis
for a classification, albeit somewhat basic. Thus, Farr’s
groups included endemic and epidemic diseases, typically
caused by infections, sporadic diseases, including many
non-communicable diseases, and violence. Within these
categories there was an attempt, albeit imperfect, to link
causes to organs, to the extent that this was possible given
the rudimentary knowledge of body systems at the time.
Although their classifications were used by their compa-
triots, they spread little further, reflecting a view that clas-
sification of disease may be impossible because of the
diversity in terminology used by physicians.
Yet some were not discouraged. One was Dr Jacques
Bertillon, a French physician who would go on to de-
velop the first recognisably modern classification of
causes of death, with 14 chapters listed mostly according
to body system [5]. Bertillon is rightly celebrated for his
innovation, paving the way for modern epidemiology.
However, as he was preparing his system in 1893, his task
was somewhat simpler than it would be today. In most
cases, those who died did so from a single cause of death,
often an injury or an infection. An extended and revised
version of this system would be adopted in 1900 as the
International Classification of Causes of Death (ICD), with
the recommendation that it be revised every 10 years.
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Chronic disease and the rising burden of
multi-morbidity
Twenty-one years later, two Canadian physicians made a
discovery that could change the nature of medicine.
Banting and Best developed a way of extracting insulin
from the pancreas, thereby offering a means to treat what
had, until then, been a rapidly fatal disease of childhood,
type I diabetes [6]. For the first time, it became possible
for people afflicted with a severe non-communicable dis-
ease to achieve a virtually normal lifespan. During those
additional years they would be exposed to the same risks
as anyone else, causing some to die prematurely from, for
example, road traffic accidents or influenza. However, by
the 1940s, it was clear that those with type I diabetes also
faced a considerably elevated risk of a number of other
health problems, affecting their vision, their cardiovascu-
lar system, their kidneys, and the peripheral nervous
system among others. Slowly, these problems were recog-
nised as the complications of diabetes, even though some
of them, such as ischaemic heart disease, were also com-
mon in those without diabetes [7]. This poses a funda-
mental challenge for the epidemiologist. When someone
with type I diabetes dies from a heart attack, is this
because of the fact that they smoked heavily or is it be-
cause of their diabetes? And as diabetes affected so many
body systems, some unfortunate individuals may suffer
from damage to many organs. Which kills them? As if that
wasn’t complex enough, the introduction of one after an-
other life prolonging treatments, such as dialysis for kid-
ney failure, keeps people alive as their diseases processes
progressed, allowing time for complications of those treat-
ments to emerge. Today, older patients may be living with
perhaps eight or nine different medical conditions [8].
This is the situation that Goldberger and colleagues have
sought to untangle. They were at least able to benefit from
the fact that the names given to diseases are no longer
arbitrary. However, as they show, the attribution of death
to a single cause is still challenging, over a century since
Farr noted how “in many cases the primary cause can, but
in many cases it cannot be discovered” [9].
Given that many people with die with, or from, several
conditions, how does one decide which is most import-
ant? Initially, countries made their own choices about how
these decisions would be made, how many causes of death
they would record on a death certificate, and how to allo-
cate a main cause where several were present. A common
structure was proposed at the Fifth Decennial Conference
on the ICD, in 1938 but not adopted until 1948. This
specified the immediate cause of death along with its ante-
cedents, as well as other significant conditions contribut-
ing to the death but unrelated to the immediate cause and
gave rise to the death certificate used today. The problem
of attribution had long been recognised, including by
Bertillon who had proposed some basic rules. However,
the task was far from straightforward. By 1925 a Manual
of Joint Causes of Death had been prepared, although with
a caveat that it was “a temporary guide for those who are
groping for help in making their assignments, rather than
an authoritative manual”. This guidance was subsequently
refined and incorporated within the International Classifi-
cation of Diseases. However, no matter how precise any
coding rules might be, they depend fundamentally on the
accuracy and completeness of recording of causes of death.
Accuracy of death certification and the
use of autopsy
There are concerns about the accuracy of what is written
on the death certificate everywhere. The diagnosis may
simply be wrong or it may be vague, giving rise to the
term “junk codes”, which although appearing in the ICD,
are non-specific and of little help in identifying the under-
lying risk factors. In many countries, the problem is grow-
ing because of the marked reduction in the number of
autopsies being conducted, in part because of the costs
involved but also, in some cases, because of resistance by
relatives of the deceased. Autopsies are permitted under
all three of the Abrahamic religions represented in Israel,
although in both Judaism [10] and Islam [11] there are
certain aspects that continue to be debated and there is
not unanimity among all of the branches of any of the
three religions. Thus, autopsies are rejected by some ultra-
orthodox Jewish groups, who succeeded in making Israeli
law more restrictive in 1980. However, there is now a
non-invasive virtual alternative, post-mortem compu-
terised tomography scanning. This was first systematically
compared with conventional autopsy in a 1994 study con-
ducted in Israel [12]. The findings from conventional and
virtual autopsy were compared, with the physicians in-
volved being blind to the others’ findings. They concluded
that both methods identified conditions missed by the
other and, ideally, the two would be combined to maxi-
mise the yield of diagnostic information. Since then, con-
siderable experience has been accumulated with a wide
range of non-invasive and minimally invasive methods
and a recent systematic review has concluded that the
maximum diagnostic yield is achieved by combining
standard computerised tomography, computerised tomo-
graphic angiography, and biopsies, but if micro-invasive
methods cannot be used then computerised tomography
should be combined with magnetic resonance imaging
[13]. However, while these approaches offer important
new possibilities, recent experience in Jerusalem, where
virtual autopsies are conducted regularly, suggests that
those opposed to conventional autopsy will also reject
virtual autopsy [14]. Moreover, while real or virtual autop-
sies may clarify what conditions are present, it is often
only the first step to deciding the cause of death.
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Multiple causes of death
The problems arising from multiple causes of death
were first described in detail by Janssen, in the late
1930s in the United States [15]. He noted how 72 % of
death certificates from New York contained more than
one cause of death whereas the corresponding figure
from Arizona was 35 %. Yet the differences were not
simply geographical. As he noted, there was an “almost
uniform lack of detail” on certificates for African-
Americans. He also noted the considerable variation in
the probability that a particular condition listed on the
death certificate would be identified as the primary cause
of death. Thus, there were twice as many death certifi-
cates mentioning alcoholism as those where it was listed
as the primary cause. For pneumonia, the difference was
threefold. Subsequent studies have shown how the prob-
ability of there being multiple causes on the death cer-
tificate varies according to the immediate cause, being
low for cancer, for example [16].
In some cases this may not matter. Goldacre and col-
leagues have shown how, in over 96 % of death certifi-
cates where a cause of death was mentioned, acute
myocardial infarction was recorded as the underlying
cause and this did not change over a 10 year time period
[17]. In other situations, such as studies of infant mortal-
ity [18] or cancer deaths [19] differences in which cause
is selected as the main one leading to death can be im-
portant. However, what is essential is that it is at last
considered in international comparisons of cause of
death. Importantly, an increasing number of countries,
including Israel, now produce mortality statistics that
include multiple causes of death, thereby permitting
more detailed analyses of the disease burden in the
population and demographers working with these data
are developing innovative methods and shared proto-
cols [20]. Goldberger and colleagues review a number
of papers from other countries showing the benefits of
such analyses.
Conclusions and further research
Mortality statistics are among the building blocks for
health policy. One of the main goals of health policy is to
reduce disease burden and, unless this can be quantified
accurately, it is not possible either to set priorities or track
progress. The paper by Goldberger and colleagues is an
excellent practical example of what needs to be done.
What is now needed are further international studies on
the comparability of attribution of cause of death, building
on the work described by Goldberger and colleagues, as
well as studies of the effectiveness of interventions to
improve the quality of coding. Finally, those engaged in
health policy must be made aware of the caveats to be ob-
served when making international comparisons of disease
outcomes, something that they sometimes fail to do [21].
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